08/26/2025 3:18 PM | Lazar David E. (Reporting) NovaBay Pharmaceuticals (Issuer) NovaBay Pharmaceuticals, Inc. (Issuer)
| Form 3 Initial statement of beneficial ownership of securities | |
08/26/2025 3:06 PM | NovaBay Pharmaceuticals (Filer) NovaBay Pharmaceuticals, Inc. (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/26/2025 3:11 PM | Lazar David E. (Filed by) NovaBay Pharmaceuticals (Subject) NovaBay Pharmaceuticals, Inc. (Subject)
| Form SCHEDULE 13D | |
08/19/2025 4:29 PM | NovaBay Pharmaceuticals (Filer) NovaBay Pharmaceuticals, Inc. (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/14/2025 3:36 PM | NovaBay Pharmaceuticals (Filer) NovaBay Pharmaceuticals, Inc. (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
06/04/2025 11:46 AM | NovaBay Pharmaceuticals (Subject) NovaBay Pharmaceuticals, Inc. (Subject) POPLAR POINT CAPITAL MANAGEMENT LLC (Filed by)
| Form SCHEDULE 13D | |
04/15/2025 11:40 AM | FAKHRY JAD (Reporting) NovaBay Pharmaceuticals (Issuer) NovaBay Pharmaceuticals, Inc. (Issuer) POPLAR POINT CAPITAL GP LLC (Reporting) POPLAR POINT CAPITAL MANAGEMENT LLC (Reporting) POPLAR POINT CAPITAL PARTNERS LP (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/15/2025 11:46 AM | FAKHRY JAD (Reporting) NovaBay Pharmaceuticals (Issuer) NovaBay Pharmaceuticals, Inc. (Issuer) POPLAR POINT CAPITAL GP LLC (Reporting) POPLAR POINT CAPITAL MANAGEMENT LLC (Reporting) POPLAR POINT CAPITAL PARTNERS LP (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/15/2025 11:50 AM | FAKHRY JAD (Reporting) NovaBay Pharmaceuticals (Issuer) NovaBay Pharmaceuticals, Inc. (Issuer) POPLAR POINT CAPITAL GP LLC (Reporting) POPLAR POINT CAPITAL MANAGEMENT LLC (Reporting) POPLAR POINT CAPITAL PARTNERS LP (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/15/2025 11:11 AM | FAKHRY JAD (Reporting) NovaBay Pharmaceuticals (Issuer) NovaBay Pharmaceuticals, Inc. (Issuer) POPLAR POINT CAPITAL GP LLC (Reporting) POPLAR POINT CAPITAL MANAGEMENT LLC (Reporting) POPLAR POINT CAPITAL PARTNERS LP (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/15/2025 11:18 AM | FAKHRY JAD (Reporting) NovaBay Pharmaceuticals (Issuer) NovaBay Pharmaceuticals, Inc. (Issuer) POPLAR POINT CAPITAL GP LLC (Reporting) POPLAR POINT CAPITAL MANAGEMENT LLC (Reporting) POPLAR POINT CAPITAL PARTNERS LP (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
Get the Latest News and Ratings for NBY and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for NovaBay Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.
|
04/15/2025 11:22 AM | FAKHRY JAD (Reporting) NovaBay Pharmaceuticals (Issuer) NovaBay Pharmaceuticals, Inc. (Issuer) POPLAR POINT CAPITAL GP LLC (Reporting) POPLAR POINT CAPITAL MANAGEMENT LLC (Reporting) POPLAR POINT CAPITAL PARTNERS LP (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/15/2025 11:30 AM | FAKHRY JAD (Reporting) NovaBay Pharmaceuticals (Issuer) NovaBay Pharmaceuticals, Inc. (Issuer) POPLAR POINT CAPITAL GP LLC (Reporting) POPLAR POINT CAPITAL MANAGEMENT LLC (Reporting) POPLAR POINT CAPITAL PARTNERS LP (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/07/2025 3:30 PM | FAKHRY JAD (Reporting) NovaBay Pharmaceuticals (Issuer) NovaBay Pharmaceuticals, Inc. (Issuer) POPLAR POINT CAPITAL GP LLC (Reporting) POPLAR POINT CAPITAL MANAGEMENT LLC (Reporting) POPLAR POINT CAPITAL PARTNERS LP (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
03/19/2025 3:33 PM | NovaBay Pharmaceuticals (Filer) NovaBay Pharmaceuticals, Inc. (Filer)
| Form DEF 14A | |
03/11/2025 3:35 PM | NovaBay Pharmaceuticals (Filer) NovaBay Pharmaceuticals, Inc. (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/07/2025 6:07 AM | NovaBay Pharmaceuticals (Filer) NovaBay Pharmaceuticals, Inc. (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/07/2025 6:08 AM | NovaBay Pharmaceuticals (Filer) NovaBay Pharmaceuticals, Inc. (Filer)
| Form DEFA14A | |
02/06/2025 5:30 PM | NovaBay Pharmaceuticals (Subject) NovaBay Pharmaceuticals, Inc. (Subject) POPLAR POINT CAPITAL MANAGEMENT LLC (Filed by)
| Form SCHEDULE 13G/A | |
02/04/2025 3:58 PM | NovaBay Pharmaceuticals (Filer) NovaBay Pharmaceuticals, Inc. (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/04/2025 3:58 PM | NovaBay Pharmaceuticals (Filer) NovaBay Pharmaceuticals, Inc. (Filer)
| Form DEFA14A | |
01/23/2025 7:12 AM | NovaBay Pharmaceuticals (Filer) NovaBay Pharmaceuticals, Inc. (Filer)
| Form DEFA14A | |
01/23/2025 7:13 AM | NovaBay Pharmaceuticals (Filer) NovaBay Pharmaceuticals, Inc. (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/22/2025 3:27 PM | NovaBay Pharmaceuticals (Filer) NovaBay Pharmaceuticals, Inc. (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/10/2025 5:06 PM | NovaBay Pharmaceuticals (Subject) NovaBay Pharmaceuticals, Inc. (Subject) POPLAR POINT CAPITAL MANAGEMENT LLC (Filed by)
| Form SCHEDULE 13G | |
01/10/2025 6:03 AM | NovaBay Pharmaceuticals (Filer) NovaBay Pharmaceuticals, Inc. (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
12/19/2024 6:00 AM | NovaBay Pharmaceuticals (Filer) NovaBay Pharmaceuticals, Inc. (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
12/11/2024 3:12 PM | NovaBay Pharmaceuticals (Filer) NovaBay Pharmaceuticals, Inc. (Filer)
| Form DEFA14A | |
12/09/2024 6:05 AM | NovaBay Pharmaceuticals (Filer) NovaBay Pharmaceuticals, Inc. (Filer)
| Form DEFA14A | |
11/26/2024 3:08 PM | NovaBay Pharmaceuticals (Filer) NovaBay Pharmaceuticals, Inc. (Filer)
| Form DEFA14A | |
11/22/2024 3:27 PM | NovaBay Pharmaceuticals (Filer) NovaBay Pharmaceuticals, Inc. (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/15/2024 7:10 AM | NovaBay Pharmaceuticals (Filer) NovaBay Pharmaceuticals, Inc. (Filer)
| Form DEFA14A | |
11/13/2024 4:15 PM | NovaBay Pharmaceuticals (Filer) NovaBay Pharmaceuticals, Inc. (Filer)
| Form DEFA14A | |
11/12/2024 3:52 PM | NovaBay Pharmaceuticals (Filer) NovaBay Pharmaceuticals, Inc. (Filer)
| Form DEFA14A | |
11/08/2024 4:31 PM | Hudson Bay Capital Management LP (Filed by) NovaBay Pharmaceuticals (Subject) NovaBay Pharmaceuticals, Inc. (Subject)
| Form SC 13G/A | |
11/06/2024 3:46 PM | NovaBay Pharmaceuticals (Filer) NovaBay Pharmaceuticals, Inc. (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/29/2024 7:15 AM | NovaBay Pharmaceuticals (Filer) NovaBay Pharmaceuticals, Inc. (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/29/2024 7:19 AM | NovaBay Pharmaceuticals (Filer) NovaBay Pharmaceuticals, Inc. (Filer)
| Form DEFA14A | |
10/16/2024 3:27 PM | NovaBay Pharmaceuticals (Filer) NovaBay Pharmaceuticals, Inc. (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/16/2024 3:19 PM | NovaBay Pharmaceuticals (Filer) NovaBay Pharmaceuticals, Inc. (Filer)
| Form DEFM14A | |
09/25/2024 4:17 PM | NovaBay Pharmaceuticals (Filer) NovaBay Pharmaceuticals, Inc. (Filer)
| Form PREM14A | |
Small Washington, DC Group Could Crash US Stocks (Ad) New Amazon Crisis Could Tank U.S. Stock Market
A new panic is halting AI projects at Amazon and could split the entire U.S. market in two on or before Sept 30, causing a crisis "many times worse than 2008." Click here for full details while you still have time to move your money. |
09/20/2024 7:08 AM | NovaBay Pharmaceuticals (Filer) NovaBay Pharmaceuticals, Inc. (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/20/2024 7:08 AM | NovaBay Pharmaceuticals (Filer) NovaBay Pharmaceuticals, Inc. (Filer)
| Form DEFA14A | |